ESTELLE-35 (84 tablets)

The chemical name of ethinyloestradiol is 19-Nor-17a-pregna-1,3,5(10)-trien-20-yne-3,17-diol, the chemical formula is C20H24O2 and the molecular weight is 296.4. Pack quantities: Three calendar packs of 21 tablets. Indications: ESTELLE-35 and ESTELLE-35 ED are indicated for the treatment of androgen dependent diseases in women, such as acne (where oral antibiotics or local treatment alone has not been successful), especially pronounced forms and those which are accompanied by seborrhoea or by inflammation or formation of nodes (acne papulopustulosa, acne nodulocystica), androgenic alopecia, mild forms of hirsutism. ESTELLE-35 and ESTELLE-35 ED are also indicated for oral contraception in women requiring treatment for these androgen-dependent diseases; it is not recommended in women solely for contraception. ESTELLE-35 is also indicated for treating the symptoms of polycystic ovary syndrome. Presentation: One calendar pack contains 21 yellowish buff, round, biconvex, active tablets plain on both sides, with a diameter of 5.0 mm. Each tablet contains 2 mg cyproterone acetate and 35 micrograms (0.035 mg) ethinyloestradiol. Storage: Shelf life is 3 years. Store below 30 °C.